ArticleFrontiers in pediatrics2019

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth.

Rezan Topaloğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.